05.23.12
Greatbatch Inc, currently based in Clarence, N.Y., will move its headquarters to Frisco, Texas, beginning this summer. The company will remain in the Clarence area where Wilson Greatbatch founded the medical device company in 1970, but its central operations will now be in the Lone Star State. Clarence R&D, manufacturing and corporate offices will remain intact, as well as all jobs.
For several years now, Greatbatch has been growing. The company has added more than 20 locations worldwide as part of its plan to enter into emerging markets in Asia, and has made a concerted effort to increase profitability in its core markets: cardiac, neurology, vascular and orthopedic. The move to Texas is a large step toward establishing itself as a medtech leader, according to company brass. In Frisco, Greatbatch will have access to the Dallas/Fort Worth International Airport—a large global access point—as well as a medical device community with a strong business climate.
"The Dallas-Ft. Worth metro area is a recognized medical device cluster surrounded by a business community that includes leading medical technology and electronics firms, as well as academic research institutions and industry opinion leaders," said Thomas J. Hook, president and CEO of Greatbatch. "While we anticipate expanding our presence at the new headquarters location in the years ahead, we also remain firmly committed to our more than 700 associates in western New York, as well as the local community. The high-quality work of our western New York associates is vital to our future and our associates here will remain an integral part of Greatbatch's success."
This summer, the first phase of the move will begin including the relocation of several executive team members. Greatbatch will continue to move operations over slowly as warranted by business.
For several years now, Greatbatch has been growing. The company has added more than 20 locations worldwide as part of its plan to enter into emerging markets in Asia, and has made a concerted effort to increase profitability in its core markets: cardiac, neurology, vascular and orthopedic. The move to Texas is a large step toward establishing itself as a medtech leader, according to company brass. In Frisco, Greatbatch will have access to the Dallas/Fort Worth International Airport—a large global access point—as well as a medical device community with a strong business climate.
"The Dallas-Ft. Worth metro area is a recognized medical device cluster surrounded by a business community that includes leading medical technology and electronics firms, as well as academic research institutions and industry opinion leaders," said Thomas J. Hook, president and CEO of Greatbatch. "While we anticipate expanding our presence at the new headquarters location in the years ahead, we also remain firmly committed to our more than 700 associates in western New York, as well as the local community. The high-quality work of our western New York associates is vital to our future and our associates here will remain an integral part of Greatbatch's success."
This summer, the first phase of the move will begin including the relocation of several executive team members. Greatbatch will continue to move operations over slowly as warranted by business.